🇺🇸 FDA
Patent

US 11673898

Substituted inhibitors of menin-MLL and methods of use

granted A61PA61P35/00

Quick answer

US patent 11673898 (Substituted inhibitors of menin-MLL and methods of use) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P35/00